Skip to content

To compare how well Panchsam Churna and Vaishvanar Churna work when used with Maharasnadi Kwath in Amvata

A comparative clinical study of Panchsam Churna and Vaishvanar Churna with Maharasnadi Kwath in Amavata - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091463
Enrollment
60
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Patients with classical features of Amavata like Angmard, Aruchi, Trishna, Aalasya, Gaurava, Jwar, Shotha, Stabdhta. b. Patients who fullfill the EULAR Classification Criteria for RA with less than 5 years of chronicity. c. Patients of either sex and socio-economic status with age between 20 and 65 years. d. Willing and able to participate in the study and ready to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1 Patients with uncontrolled Hypertension (more than 160/100 mm of Hg) and diabetes mellitus 2 Patients diagnosed with other types of arthritis like gouty arthritis, tuberculous arthritis etc. 3 Patients with bone deformities like Swan neck deformity, Boutonniere deformity and rheumatic nodules 4 Patients on prolonged medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. 5 Patients who have a past history of any major systemic disorder like CA, CRF, Liver cirrhosis, CAD etc. 6 Pregnant and lactating mother.

Design outcomes

Primary

MeasureTime frame
Changes in Clinical presentation of Amavata assessed through- 1. Change in DAS 28 Score 2. Change in RAPID 3 Score 3. Improvement in Objective Parameters like RA Factor and CRP 4. Change in Subjective Parameters like- Sparshasahyata, Sandhishoth, Gauravata, Aruchi, Jwar, Sandhi shool Timepoint: base line assessment ( day 0) mid treatment assessment (day 15) post treatment assessment (day 30)

Secondary

MeasureTime frame
improvement in quality of life assessed through patient reported feedbackregarding daily activities and overall wellbeingTimepoint: base line assessment ( day 0) mid treatment assessment (day 15) post treatment assessment (day 30)

Countries

India

Contacts

Public ContactDr Shubham Sadh

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

shubhamsadh@gmail.com8792429267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026